Clinical Practice Reviewer Reports

On this page ...

What is a clinical practice reviewer report?

A clinical practice reviewer report is a short review that captures a clinician’s input and advice about a specific drug and indication. Clinical practice reviewer reports allow B.C. clinicians to contribute their clinical practice experience and drug- or indication-specific expertise to PharmaCare drug coverage decisions.

We Need Your Input

The Drug Review Resource Committee, a sub-committee of the Drug Benefit Council, establishes the review requirements, including the type of clinical reports required for drugs under review. With the Drug Review Resource Committee’s oversight, the ministry seeks general practitioners and medical specialists who are willing to offer their expertise and advice, in the form of a clinical practice reviewer report, about the therapeutic value and cost-effectiveness of certain drug therapies. Clinical practice reviewer reports are confidential and supplement existing studies and data with clinical practice advice. The reports allow clinicians to engage with the drug review process and decision-making, as well as increase the expertise available for drug reviews.

Drugs Under Review

The ministry is currently seeking clinicians to provide input on the drugs listed below. If you would like to be considered as a clinical practice reviewer, all required application documents (including your resume, Confidentiality Agreement, and Conflict of Interest Declaration) must be submitted to DrugReviewProcess@gov.bc.ca during the recruitment period indicated below.

Drug Name (Generic) Drug Name (Trade/Brand) Indication Reviewers Required Clinician Recruitment Period CPR Report Due
reslizumab Cinqair eosinophilic asthma

General practitioners

Respirologist

Late November 2016 Mid-January 2017
propanolol oral solution Hemangiol infantile hemangioma

Pediatric dermatologist

Dermatologist

Late November 2016 Mid-January 2017

How are reviewers selected?

The Drug Review Resource Committee selects a clinician to prepare a clinical practice reviewer report according to the particular drug submission under review. When selecting a reviewer, the committee assesses the review requirements of the particular drug submission, the expertise of the potential reviewer, and compares the conflict of interest information declared by the reviewer with the Conflict of Interest Guideline (PDF). Whenever possible, the committee will select an appropriate reviewer without a conflict of interest. However, the committee may select a reviewer with an identified conflict of interest after weighing the potential benefits and risks of including the participant in the review.

What are clinicians asked to provide?

Clinicians are asked to prepare a clinical practice reviewer report, involving the following components.

Reviewing documents for the specified drug and/or indication

Clinicians are required to read a short drug review summary, as well as the overview or executive summary portion of other documents, depending on the clinician’s experience and the drug under review.

 

Documents for your review may include:

  • Drug review summary
  • Budget analysis (executive summary)
  • Clinical review report (executive summary)
  • National Common Drug Review drug listing recommendation
  • Pharmacoeconomic review

Preparing a concise, informative, 3 5 page review that responds to specific questions provided

Example questions:

  • Respond based on your experience
  • Discuss the experience(s) of your peer group
  • You are not expected to re-write or to prepare clinical trials. 

Advising of other factors that should be considered

Examples:

  • Desired treatment outcome goals
  • Standard treatment options (drug and non-drug) and place in therapy
  • Treatment impact on your practice and patients.
  • Applicability and interpretation of available clinical evidence on decision making
  • Appropriate patients to receive drugs under review
  • Potential product utilization, including off-label use
  • Any clinical trial data of which you are aware that was not included in the analysis

Discussing whether the documents and analysis are what you see, or expect to see, for a condition in B.C. patients

 

Examples:

  • Incidence
  • Disease prevalence
  • Diagnosis
  • Natural disease history
  • Patient populations
  • Standards of therapy

Indicating agreement or disagreement with the Common Drug Review recommendation

  • If applicable

Sending in any additional information you think the Drug Benefit Council and/or ministry should take into account

  • Optional

How to use Clinical Practice Reviews as Maintenance of Certification or Mainpro Credits

Do you participate in the Royal College of Physicians and Surgeons’ Maintenance of Certification Program (MOC Program) or the College of Family Physicians of Canada Maintenance of Proficiency (Mainpro®) program? If so, you can claim your completed clinical practice reviewer report as continuing professional development/continuing medical education and receive either MOC Program or Mainpro-M2 credits.

  • When entering this continuing professional development/continuing medical education activity in your Royal College MAINPORT ePortfolio, enter your completed clinical practice reviewer report and involvement as a clinical practice reviewer to claim 15 credits. Note that:
    • Clinicians who complete clinical practice reviewer reports for the Ministry of Health are entitled to claim 15 credits once per year for the writing of reports, regardless of how many reports you prepare in a year. Claim your 15 credits under  Section 2 – Systems Learning: Peer Review.
    • Clinicians may also claim 2 credits per hour for time spent above and beyond the basic work counted for the 15 credits (e.g., if you must research or review certain materials and gain further knowledge as part of preparing your report). Claim your 2 credits per hour, per clinical practice reviewer report, under Section 2 – Personal Learning Project. Personal learning project credits may be claimed regardless of how many reports you complete, provided that you researched or reviewed materials to gain further knowledge as part of preparing your clinical practice reviewer report. To claim these credits, you will be asked to identify the subject of your research, the date, and the impact this learning has on your practice.
  • When entering this continuing professional development/continuing medical education activity in your College of Family Physicians Mainpro® portfolio, list your  involvement as a clinical practice reviewer under Mainpro-M2 activities to receive one credit per hour of participation.

Join Our Clinician Roster

Are you interested in participating in the drug review process as a clinical practice reviewer? Submit your name, contact information, areas of specialization, expertise and/or medical practice interest to DrugReviewProcess@gov.bc.ca.